Intelligence · Patents
Patents expiring in 2030
Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.
- Patents
- 880
Quick answer
880 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7790182
Protein vaccines against poxviruses
granted -
US 7790764
Biologically active macrolides, compositions, and uses thereof
granted -
US 7790755
Controlled release preparation
granted -
US 7790878
RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof
granted -
US 7790860
Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids
granted -
US 7790899
Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
granted -
US 7790835
Method of preparing maleimide functionalized polymers
granted -
US 7790766
Pharmaceutical compositions of short-acting sedative hypnotic agent
granted -
US 7790738
Methods of treating and preventing AIDS using of COX-2 inhibitors
granted -
US 7790734
Dipeptidyl peptidase inhibitors
granted -
US 7790728
Pyrazine derivatives useful as adenosine receptor antagonists
granted -
US 7790735
Methanocarba cycloalkyl nucleoside analogues
granted -
US 7790186
Plasmodium vivax hybrid circumsporozoite protein and vaccine
granted -
US 7790703
Phosphonate compounds
granted -
US 7790433
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
granted -
US 7790181
Live attenuated viral vaccines for Eastern Equine Encephalitis virus
granted -
US 7790159
Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
granted -
US 7795209
Anti-angiogenic methods and compositions
granted -
US 7794998
Primate T-lymphotropic viruses
granted -
US 7794734
Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever
granted -
US 7794726
Mutants of lysine decarboxylase, vaccines for periodontitis, and methods of use
granted -
US 7794730
Polyvalent attenuated live vaccine for preventing and curing vibriosis of cultivated fish
granted -
US 7794714
Newcastle disease virus monoclonal antibodies
granted -
US 7794728
Attenuated Listeria spp. and methods for using the same
granted -
US 7794957
Eukaryotic genes involved in adult lifespan regulation
granted -
US 7795208
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
granted -
US 7795495
Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them
granted -
US 7795428
Dipeptidyl peptidase inhibitors
granted -
US 7795305
CDDO-compounds and combination therapies thereof
granted -
US 7794717
High affinity human antibodies to human IL-4 receptor
granted -
US 7795386
Peptides comprising an isoDGR motif
granted -
US 7795389
Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combination or as fusion proteins
granted -
US 7795302
Use of compositions for treating rosacea
granted -
US 7795300
External preparation for skin
granted -
US 7795295
Small molecule inhibition of PDZ-domain interaction
granted -
US 7795267
Bicyclic piperazine compound having TGR23 antagonistic activity
granted -
US 7795259
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
granted -
US 7795274
5-lipoxygenase-activating protein (FLAP) inhibitors
granted -
US 7799753
Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents
granted -
US 7799798
Spiroheterocyclic compounds and their uses as therapeutic agents
granted -
US 7799777
Salts of potassium ATP channel openers and uses thereof
granted -
US 7799822
Phenyl sulfonamides as modulators of ion channels
granted -
US 7799518
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
granted -
US 7799329
Viruses for the treatment of cellular proliferative disorders
granted -
US 7799762
Acyl pseudodipeptides which carry a functionalised auxialiary arm
granted -
US 7799533
Polypeptides, their production and use
granted -
US 7799070
Coated implantable medical device
granted -
US 7799789
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
granted
Frequently asked questions
How many pharma patents expire in 2030?
880 published patents in our USPTO index have expiration dates falling in calendar year 2030.